Design considerations for a multiple sclerosis fatigue mobile app MS Energize: A pragmatic iterative approach using usability testing and resonance checks.
App design
Fatigue
Multiple sclerosis
Usability testing
mHealth
Journal
Internet interventions
ISSN: 2214-7829
Titre abrégé: Internet Interv
Pays: Netherlands
ID NLM: 101631612
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
21
09
2020
revised:
19
01
2021
accepted:
22
01
2021
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
epublish
Résumé
Multiple sclerosis (MS) is a chronic neurological condition affecting around 2.2 million people worldwide. The illness includes a range of symptoms, with fatigue considered to be one of the most disabling. This paper describes how a pragmatic and iterative approach, supported by usability and resonance testing, was used to build a minimum viable product of MS Energize-or MS Energise in UK English regions. MS Energise is a mobile application focused on self-management of fatigue for people with MS. The iterative approach included various stages of testing, during which user feedback including comments about interface, navigation and content, was sought to inform incremental app development and continual improvement. Usability testing was conducted with 11 people with longstanding multiple sclerosis in New Zealand and the United Kingdom, and focused on particular sections of the app as well as the accessibility of the app to users with MS. Two participants contributed to further resonance testing post-release to ensure the app was perceived as relevant and useful to the user. The usability testing and resonance testing phases suggested that user experience of MS Energise was mostly positive. Participants provided a number of suggestions for improvements to aspects of content and design; some of which we implemented during our app development process. Findings will also contribute to future planning and design iteration to enhance the user experience. The next step is further improvement of MS Energise prior to a trial of its clinical and cost effectiveness.
Identifiants
pubmed: 33614414
doi: 10.1016/j.invent.2021.100371
pii: S2214-7829(21)00011-7
pmc: PMC7878181
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100371Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The software package that is the focus of this paper has been released through the iOS app store. Kersten, Van Kessel and Babbage are the inventors of the product. Both Auckland University of Technology and Bournemouth University may receive royalty payments associated with sales of the software.
Références
J Med Internet Res. 2017 May 10;19(5):e153
pubmed: 28490417
Expert Rev Neurother. 2010 Sep;10(9):1437-47
pubmed: 20819014
JMIR Res Protoc. 2020 Feb 14;9(2):e15969
pubmed: 32130185
JMIR Mhealth Uhealth. 2016 Sep 09;4(3):e107
pubmed: 27613084
J Psychosom Res. 2006 Nov;61(5):583-5
pubmed: 17084134
J Pain Symptom Manage. 2020 Feb;59(2):242-253
pubmed: 31539601
Internet Interv. 2019 Nov 09;18:100291
pubmed: 31890637
Disabil Rehabil. 2018 Jun;40(12):1434-1442
pubmed: 28322588
BMJ Glob Health. 2018 Feb 21;3(1):e000676
pubmed: 29527353
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1092-9
pubmed: 23695501
Med J Islam Repub Iran. 2015 Aug 30;29:255
pubmed: 26793646
J Med Internet Res. 2016 May 16;18(5):e97
pubmed: 27185295
Patient Educ Couns. 2010 Feb;78(2):240-9
pubmed: 19665337
Mult Scler Relat Disord. 2019 Jan;27:13-19
pubmed: 30296732
JMIR Mhealth Uhealth. 2018 Feb 09;6(2):e37
pubmed: 29426814
Am J Prev Med. 2016 Nov;51(5):843-851
pubmed: 27745684
Mult Scler Relat Disord. 2019 Jul;32:123-132
pubmed: 31125754
JMIR Mhealth Uhealth. 2017 Feb 28;5(2):e6
pubmed: 28246073
Behav Res Ther. 2012 Jun;50(6):415-21
pubmed: 22516321
Stud Health Technol Inform. 2017;242:638-641
pubmed: 28873864
J Med Internet Res. 2013 Mar 25;15(3):e69
pubmed: 23529377
Res Nurs Health. 2000 Aug;23(4):334-40
pubmed: 10940958
Brain. 2015 Jan;138(Pt 1):11-27
pubmed: 25433914
BMC Neurol. 2014 May 19;14:109
pubmed: 24886398
Disabil Rehabil Assist Technol. 2019 Nov 11;:1-6
pubmed: 31711351
Expert Opin Pharmacother. 2012 Feb;13(2):207-16
pubmed: 22220738
PLoS One. 2015 Feb 18;10(2):e0115541
pubmed: 25692993
Clin Rehabil. 2016 May;30(5):454-62
pubmed: 25952587
Mult Scler. 2017 Oct;23(11):1527-1541
pubmed: 28528565
Mult Scler. 2013 Aug;19(9):1240-1
pubmed: 23388164
JMIR Mhealth Uhealth. 2018 Mar 02;6(3):e51
pubmed: 29500159
J Med Internet Res. 2013 Apr 18;15(4):e86
pubmed: 23598614
PLoS Med. 2013;10(1):e1001362
pubmed: 23349621
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
JAMA Psychiatry. 2018 Feb 1;75(2):113-114
pubmed: 29238805
Behav Res Methods Instrum Comput. 2003 Aug;35(3):379-83
pubmed: 14587545
Psychosom Med. 2008 Feb;70(2):205-13
pubmed: 18256342
J Med Internet Res. 2012 Mar 09;14(2):e45
pubmed: 22532074
JMIR Mhealth Uhealth. 2019 Jan 15;7(1):e12297
pubmed: 30664494
NPJ Digit Med. 2018 Sep 13;1:46
pubmed: 31304326
Biomed Instrum Technol. 2012 Fall;Suppl:49-56
pubmed: 23039777
Expert Rev Neurother. 2017 Apr;17(4):373-379
pubmed: 27728987